ORG Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.35M Buy
11,334
+728
+7% +$144K 0.41% 49
2025
Q3
$1.97M Buy
10,606
+7,354
+226% +$1.26M 0.36% 58
2025
Q2
$507K Buy
3,252
+60
+2% +$9.22K 0.11% 169
2025
Q1
$414K Sell
3,192
-461
-13% -$72.1K 0.1% 163
2024
Q4
$529K Buy
3,653
+3
+0.1% +$465 0.07% 178
2024
Q3
$592K Sell
3,650
-2,939
-45% -$468K 0.09% 150
2024
Q2
$967K Buy
6,589
+6,083
+1,202% +$905K 0.12% 144
2024
Q1
$80K Sell
506
-10,910
-96% -$1.74M 0.15% 89
2023
Q4
$1.79M Buy
11,416
+4,437
+64% +$680K 0.3% 66
2023
Q3
$1.09M Sell
6,979
-3,165
-31% -$522K 0.32% 68
2023
Q2
$1.67M Buy
+10,144
New +$1.64M 0.27% 78

Other funds holding JNJ

ORG Partners's JNJ Position: Q4 2025 in Review

ORG Partners increased its Johnson & Johnson (JNJ) stake by 6.9% in Q4 2025, buying an estimated $144K and bringing the position to 11,334 shares worth $2.35M. The position accounts for 0.41% of the portfolio, ranked #49.

ORG Partners first reported a position in JNJ in Q2 2023 and has held it in 11 quarters since. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • ORG Partners held 11,334 shares of Johnson & Johnson worth $2.35M as of Q4 2025.
  • ORG Partners bought 728 Johnson & Johnson shares in Q4 2025, an estimated $144K.
  • Johnson & Johnson made up 0.41% of ORG Partners's portfolio in Q4 2025, its #49 holding.
  • ORG Partners first reported a position in Johnson & Johnson in Q2 2023 and has held it in 11 quarters since.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.